United States Vitamin D Analogs Market Report 2016

December 2016 | 114 pages | ID: U49DB158BC4EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Vitamin D Analogs

Revenue, means the sales value of Vitamin D Analogs

This report studies sales (consumption) of Vitamin D Analogs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Blistex, Inc. (US)
• Chattem, Inc. (US)
• ConvaTec (US)
• Galderma Pharma SA (Switzerland)
• Henkel AG & Co. KgaA (Germany)
• Johnson & Johnson (US)
• Neutrogena Corp (US)
• Merck & Co. (US)
• Novartis AG (Switzerland)
• Obagi Medical Products, Inc. (US)
• Procter & Gamble Company (US)
• Reckitt Benckiser Plc. (UK)
• Rohto Pharmaceutical Co., Ltd. (Japan)
• Shiseido Co., Ltd. (Japan)
• Unilever NV (The Netherlands)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Vitamin D Analogs in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Vitamin D Analogs Market Report 2016

1 VITAMIN D ANALOGS OVERVIEW

1.1 Product Overview and Scope of Vitamin D Analogs
1.2 Classification of Vitamin D Analogs
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Vitamin D Analogs
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Vitamin D Analogs (2011-2021)
  1.4.1 United States Vitamin D Analogs Sales and Growth Rate (2011-2021)
  1.4.2 United States Vitamin D Analogs Revenue and Growth Rate (2011-2021)

2 UNITED STATES VITAMIN D ANALOGS COMPETITION BY MANUFACTURERS

2.1 United States Vitamin D Analogs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Vitamin D Analogs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Vitamin D Analogs Average Price by Manufactures (2015 and 2016)
2.4 Vitamin D Analogs Market Competitive Situation and Trends
  2.4.1 Vitamin D Analogs Market Concentration Rate
  2.4.2 Vitamin D Analogs Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES VITAMIN D ANALOGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Vitamin D Analogs Sales and Market Share by Type (2011-2016)
3.2 United States Vitamin D Analogs Revenue and Market Share by Type (2011-2016)
3.3 United States Vitamin D Analogs Price by Type (2011-2016)
3.4 United States Vitamin D Analogs Sales Growth Rate by Type (2011-2016)

4 UNITED STATES VITAMIN D ANALOGS SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Vitamin D Analogs Sales and Market Share by Application (2011-2016)
4.2 United States Vitamin D Analogs Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES VITAMIN D ANALOGS MANUFACTURERS PROFILES/ANALYSIS

5.1 Blistex, Inc. (US)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Vitamin D Analogs Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Blistex, Inc. (US) Vitamin D Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Chattem, Inc. (US)
  5.2.2 Vitamin D Analogs Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Chattem, Inc. (US) Vitamin D Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 ConvaTec (US)
  5.3.2 Vitamin D Analogs Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 ConvaTec (US) Vitamin D Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Galderma Pharma SA (Switzerland)
  5.4.2 Vitamin D Analogs Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Galderma Pharma SA (Switzerland) Vitamin D Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Henkel AG & Co. KgaA (Germany)
  5.5.2 Vitamin D Analogs Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Henkel AG & Co. KgaA (Germany) Vitamin D Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Johnson & Johnson (US)
  5.6.2 Vitamin D Analogs Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Johnson & Johnson (US) Vitamin D Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Neutrogena Corp (US)
  5.7.2 Vitamin D Analogs Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Neutrogena Corp (US) Vitamin D Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Merck & Co. (US)
  5.8.2 Vitamin D Analogs Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Merck & Co. (US) Vitamin D Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Novartis AG (Switzerland)
  5.9.2 Vitamin D Analogs Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Novartis AG (Switzerland) Vitamin D Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Obagi Medical Products, Inc. (US)
  5.10.2 Vitamin D Analogs Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Obagi Medical Products, Inc. (US) Vitamin D Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Procter & Gamble Company (US)
5.12 Reckitt Benckiser Plc. (UK)
5.13 Rohto Pharmaceutical Co., Ltd. (Japan)
5.14 Shiseido Co., Ltd. (Japan)
5.15 Unilever NV (The Netherlands)

6 VITAMIN D ANALOGS MANUFACTURING COST ANALYSIS

6.1 Vitamin D Analogs Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Vitamin D Analogs

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Vitamin D Analogs Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Vitamin D Analogs Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES VITAMIN D ANALOGS MARKET FORECAST (2016-2021)

10.1 United States Vitamin D Analogs Sales, Revenue Forecast (2016-2021)
10.2 United States Vitamin D Analogs Sales Forecast by Type (2016-2021)
10.3 United States Vitamin D Analogs Sales Forecast by Application (2016-2021)
10.4 Vitamin D Analogs Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Vitamin D Analogs
Table Classification of Vitamin D Analogs
Figure United States Sales Market Share of Vitamin D Analogs by Type in 2015
Table Application of Vitamin D Analogs
Figure United States Sales Market Share of Vitamin D Analogs by Application in 2015
Figure United States Vitamin D Analogs Sales and Growth Rate (2011-2021)
Figure United States Vitamin D Analogs Revenue and Growth Rate (2011-2021)
Table United States Vitamin D Analogs Sales of Key Manufacturers (2015 and 2016)
Table United States Vitamin D Analogs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Vitamin D Analogs Sales Share by Manufacturers
Figure 2016 Vitamin D Analogs Sales Share by Manufacturers
Table United States Vitamin D Analogs Revenue by Manufacturers (2015 and 2016)
Table United States Vitamin D Analogs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Vitamin D Analogs Revenue Share by Manufacturers
Table 2016 United States Vitamin D Analogs Revenue Share by Manufacturers
Table United States Market Vitamin D Analogs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Vitamin D Analogs Average Price of Key Manufacturers in 2015
Figure Vitamin D Analogs Market Share of Top 3 Manufacturers
Figure Vitamin D Analogs Market Share of Top 5 Manufacturers
Table United States Vitamin D Analogs Sales by Type (2011-2016)
Table United States Vitamin D Analogs Sales Share by Type (2011-2016)
Figure United States Vitamin D Analogs Sales Market Share by Type in 2015
Table United States Vitamin D Analogs Revenue and Market Share by Type (2011-2016)
Table United States Vitamin D Analogs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Vitamin D Analogs by Type (2011-2016)
Table United States Vitamin D Analogs Price by Type (2011-2016)
Figure United States Vitamin D Analogs Sales Growth Rate by Type (2011-2016)
Table United States Vitamin D Analogs Sales by Application (2011-2016)
Table United States Vitamin D Analogs Sales Market Share by Application (2011-2016)
Figure United States Vitamin D Analogs Sales Market Share by Application in 2015
Table United States Vitamin D Analogs Sales Growth Rate by Application (2011-2016)
Figure United States Vitamin D Analogs Sales Growth Rate by Application (2011-2016)
Table Blistex, Inc. (US) Basic Information List
Table Blistex, Inc. (US) Vitamin D Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Blistex, Inc. (US) Vitamin D Analogs Sales Market Share (2011-2016)
Table Chattem, Inc. (US) Basic Information List
Table Chattem, Inc. (US) Vitamin D Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Chattem, Inc. (US) Vitamin D Analogs Sales Market Share (2011-2016)
Table ConvaTec (US) Basic Information List
Table ConvaTec (US) Vitamin D Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
Table ConvaTec (US) Vitamin D Analogs Sales Market Share (2011-2016)
Table Galderma Pharma SA (Switzerland) Basic Information List
Table Galderma Pharma SA (Switzerland) Vitamin D Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Galderma Pharma SA (Switzerland) Vitamin D Analogs Sales Market Share (2011-2016)
Table Henkel AG & Co. KgaA (Germany) Basic Information List
Table Henkel AG & Co. KgaA (Germany) Vitamin D Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Henkel AG & Co. KgaA (Germany) Vitamin D Analogs Sales Market Share (2011-2016)
Table Johnson & Johnson (US) Basic Information List
Table Johnson & Johnson (US) Vitamin D Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Johnson & Johnson (US) Vitamin D Analogs Sales Market Share (2011-2016)
Table Neutrogena Corp (US) Basic Information List
Table Neutrogena Corp (US) Vitamin D Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Neutrogena Corp (US) Vitamin D Analogs Sales Market Share (2011-2016)
Table Merck & Co. (US) Basic Information List
Table Merck & Co. (US) Vitamin D Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck & Co. (US) Vitamin D Analogs Sales Market Share (2011-2016)
Table Novartis AG (Switzerland) Basic Information List
Table Novartis AG (Switzerland) Vitamin D Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis AG (Switzerland) Vitamin D Analogs Sales Market Share (2011-2016)
Table Obagi Medical Products, Inc. (US) Basic Information List
Table Obagi Medical Products, Inc. (US) Vitamin D Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Obagi Medical Products, Inc. (US) Vitamin D Analogs Sales Market Share (2011-2016)
Table Procter & Gamble Company (US) Basic Information List
Table Procter & Gamble Company (US) Vitamin D Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Procter & Gamble Company (US) Vitamin D Analogs Sales Market Share (2011-2016)
Table Reckitt Benckiser Plc. (UK) Basic Information List
Table Reckitt Benckiser Plc. (UK) Vitamin D Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Reckitt Benckiser Plc. (UK) Vitamin D Analogs Sales Market Share (2011-2016)
Table Rohto Pharmaceutical Co., Ltd. (Japan) Basic Information List
Table Rohto Pharmaceutical Co., Ltd. (Japan) Vitamin D Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Rohto Pharmaceutical Co., Ltd. (Japan) Vitamin D Analogs Sales Market Share (2011-2016)
Table Shiseido Co., Ltd. (Japan) Basic Information List
Table Shiseido Co., Ltd. (Japan) Vitamin D Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Shiseido Co., Ltd. (Japan) Vitamin D Analogs Sales Market Share (2011-2016)
Table Unilever NV (The Netherlands) Basic Information List
Table Unilever NV (The Netherlands) Vitamin D Analogs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Unilever NV (The Netherlands) Vitamin D Analogs Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Vitamin D Analogs
Figure Manufacturing Process Analysis of Vitamin D Analogs
Figure Vitamin D Analogs Industrial Chain Analysis
Table Raw Materials Sources of Vitamin D Analogs Major Manufacturers in 2015
Table Major Buyers of Vitamin D Analogs
Table Distributors/Traders List
Figure United States Vitamin D Analogs Production and Growth Rate Forecast (2016-2021)
Figure United States Vitamin D Analogs Revenue and Growth Rate Forecast (2016-2021)
Table United States Vitamin D Analogs Production Forecast by Type (2016-2021)
Table United States Vitamin D Analogs Consumption Forecast by Application (2016-2021)